ARQT - ARCUTIS BIOTHERAPEUTICS INC
Healthcare · NASDAQ
Current Price
$16.89
+3.94% today
Intrinsic Value
N/A
-
Market Cap
$1.9B
+12.2% this quarter
Smart Money Holders
9
-
Net Quarterly Flow
9 net buyers
More buying
Smart Money Signals
BUYING
100%of smart money are accumulating
Momentum Score
77▲
Smart Money Conviction
0.01%low
Net Flow Signal
+9net buyers
Investor Activity
0$100M+ new
Crowding Score
26
Exit Risk
0%reducing
Recent Activity
REDUCEDQ2 2025
BlackRock, Inc
Reduced position by $19.4M (-14.0%)
REDUCING
ADDEDQ2 2025
Goldman Sachs
Increased position by $9.2M (+53.6%)
UP +50%
INVESTOR | LAST FILED | SHARES | % PORTFOLIO / VALUE | QUARTERLY ACTIVITY | HOLDING PERIOD | SIGNALS |
---|---|---|---|---|---|---|
Point72 Asset Management | 2025 Q2 | 1,485,425 | 0.04%$20.8M | +655K shares +$7.8M value | 4.5 years | INCREASINGBUILDING |
D. E. Shaw & Co | 2025 Q2 | 2,163,001 | 0.02%$30.3M | +173K shares -$791K value | 5+ years | INCREASINGUP +63%BUILDING |
BlackRock, Inc | 2025 Q2 | 8,532,761 | 0.00%$119.6M | -360K shares -$19.4M value | 5+ years | REDUCINGHIGH TURNOVER |
Vanguard Group | 2025 Q2 | 7,049,099 | 0.00%$98.8M | +231K shares -$7.8M value | 5+ years | INCREASINGBUILDINGHIGH TURNOVER |
Goldman Sachs | 2025 Q2 | 1,890,246 | 0.00%$26.5M | +787K shares +$9.2M value | 5+ years | INCREASINGUP +50%HIGH TURNOVER |
JPMorgan Chase & Co | 2025 Q2 | 548,789 | 0.00%$7.7M | +5K shares -$804K value | 5+ years | INCREASINGUP +86%HIGH TURNOVER |
AQR Capital Management | 2025 Q2 | 375,233 | 0.00%$5.3M | +127K shares +$1.4M value | 1.5 years | INCREASINGUP +53%BUILDING |
Citadel Advisors | 2025 Q2 | 145,493 | 0.00%$2M | -165K shares -$2.8M value | 5+ years | REDUCINGUP +61%HIGH TURNOVER |
Two Sigma Investments | 2025 Q2 | 71,681 | 0.00%$1M | -80K shares -$1.4M value | 4.5 years | REDUCINGUP +80% |
Smart Money Activity vs Price
TOTAL BUYS
$499.0M
TOTAL SELLS
$380.0M
NET FLOW
+$119.0M
PRICE CHANGE
-26.7%
PEAK ACTIVITY
2024 Q4